Literature DB >> 19415948

Challenges in the interpretation of peritoneal cytologic specimens.

Oscar Lin1.   

Abstract

CONTEXT: The presence of malignant cells in peritoneal washings leads to classification as International Federation of Gynecology and Obstetrics stage IC or higher in ovarian carcinomas and at least International Federation of Gynecology and Obstetrics stage IIIA in endometrial carcinomas. Unfortunately, the morphologic examination of cytologic specimens has not proven to be a sensitive or specific diagnostic tool. Malignant cells might be few in number and might be unrecognized among a large population of mesothelial cells and/or macrophages, or reactive mesothelial cells might be misinterpreted as neoplastic cells leading to unnecessary chemotherapy.
OBJECTIVE: To evaluate the main pitfalls in the evaluation of peritoneal washings in patients with gynecologic malignancies and analyze the ancillary studies that might be helpful to achieve the correct diagnosis with an emphasis on immunocytochemistry. DATA SOURCES: A comprehensive review of the literature was performed.
CONCLUSIONS: Peritoneal effusions may represent major challenges to the pathologist and can have important clinical implications. Immunostains for epithelial markers such as B72.3, MOC-31, and Ber-EP4 represent the best available markers to identify epithelial cells. Caution is advised to not overdiagnose endometriosis or endosalpingiosis as adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415948     DOI: 10.5858/133.5.739

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

Review 1.  Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.

Authors:  Sinchita Roy Chowdhuri; Patricia Fetsch; Jennifer Squires; Elise Kohn; Armando C Filie
Journal:  Diagn Cytopathol       Date:  2012-11-16       Impact factor: 1.582

Review 2.  [Use of monoclonal antibodies in pathological diagnostics].

Authors:  S Förster; A Tannapfel
Journal:  Internist (Berl)       Date:  2019-10       Impact factor: 0.743

3.  Ascites in Ovarian Carcinoma - Reliability and Limitations of Cytological Analysis.

Authors:  R Živadinović; A Petrić; D Krtinić; J Stevanović Milosević; S Pop Trajković Dinić
Journal:  West Indian Med J       Date:  2015-04-08       Impact factor: 0.171

4.  Neoplastic pericardial disease: Old and current strategies for diagnosis and management.

Authors:  Chiara Lestuzzi
Journal:  World J Cardiol       Date:  2010-09-26

5.  Use of the term atypical cells in the reporting of ascitic fluid cytology: A caveat.

Authors:  Radha Ramachandra Pai; Krithika Damodar Shenoy; Jessica Minal; Pooja K Suresh; Shrijeet Chakraborti; Flora D Lobo
Journal:  Cytojournal       Date:  2019-06-28       Impact factor: 2.091

Review 6.  Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.

Authors:  Kaname Uno; Shohei Iyoshi; Masato Yoshihara; Kazuhisa Kitami; Kazumasa Mogi; Hiroki Fujimoto; Mai Sugiyama; Yoshihiro Koya; Yoshihiko Yamakita; Akihiro Nawa; Tomohiro Kanayama; Hiroyuki Tomita; Atsushi Enomoto; Hiroaki Kajiyama
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

7.  The Incidence of Free Peritoneal Tumor Cells before and after Neoadjuvant Chemotherapy in Gastroesophageal Junction Cancer.

Authors:  Rune B Strandby; Lars B Svendsen; Rikard Ambrus; Andreas A Rostved; Jane P Hasselby; Michael P Achiam
Journal:  J Cytol       Date:  2019-12-23       Impact factor: 1.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.